Skip to main content
logo
LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
42.01
+3.92 (10.29%)
At close: Nov 6, 2026, 4:00 PM EST
42.63
+0.62 (1.48%)
After-hours: Nov 6, 2026, 7:53 PM EST

LB Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
1,355563---
Market Cap Growth
265.97%----
Enterprise Value
957252---
Last Close Price
42.0122.26---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
3.251.87---
P/TBV Ratio
3.241.87---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.010.010.19--1.12
Net Debt / Equity Ratio
-0.95-0.97-1.23-1.04-0.13
Net Debt / EBITDA Ratio
2.649.990.383.81-0.98
Net Debt / FCF Ratio
2.778.270.453.57-1.01
Quick Ratio
13.3539.673.4516.6145.64
Current Ratio
14.7841.453.5617.5145.82
Return on Equity (ROE)
-38.80%-15.70%-206.22%-63.14%-
Return on Assets (ROA)
-24.46%-10.64%-102.33%-21.18%-
Return on Capital Employed (ROCE)
-35.80%-9.70%-255.00%-26.40%-13.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-11.47%-4.48%---
FCF Yield
-10.61%-6.26%---
Buyback Yield / Dilution
-1602.13%-2145.81%-43.52%-8.02%-
SEC Filings: 10-K · 10-Q